Opioid-induced Constipation

• FDA approval · 2013-08-19
  FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)

  FDA approved a supplemental application for Lubiprostone from Dr. Reddy's Laboratories Inc.

• FDA approval · 2013-04-19
  FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)

  FDA approved a supplemental application for Lubiprostone filed by Dr. Reddy's Laboratories Inc.

• FDA approval · 2010-09-27
  FDA Approved: RELISTOR — Supplemental Application (Salix Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for RELISTOR (METHYLNALTREXONE BROMIDE) submitted by Salix Pharmaceuticals, Inc. The changes rel…

• FDA approval · 2010-07-23
  FDA Approved: RELISTOR — Supplemental Application (Salix Pharmaceuticals, Inc.)

  FDA approved a supplemental application for Relistor (methylnaltrexone bromide) submitted by Salix Pharmaceuticals, Inc.

• FDA approval · 2009-11-04
  FDA Approved: RELISTOR — Supplemental Application (Salix Pharmaceuticals, Inc.)

  FDA approved a supplemental application for RELISTOR (methylnaltrexone bromide) from Salix Pharmaceuticals. The approval updates the labelin…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2008-04-24
  FDA Approved: RELISTOR — Original Application (Salix Pharmaceuticals, Inc.)

  FDA approved RELISTOR (methylnaltrexone bromide) through its original application for the treatment of opioid-induced constipation in patien…